Phase 3 Clinical Trial of Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2(Trafermin)

Clinical trial NCT00734708 · COMPLETED

Trial details

NCT number: NCT00734708
Sponsor: Kaken Pharmaceutical
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Periodontitis Alveolar Bone Loss Periodontal Attachment Loss

Start date: 2008-08-01
Primary completion: 2010-03-01
Enrollment: 328

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.